There are 12 resources available
Welcome and introduction
Presenter: C. Marchio, IT, D. S. P. Tan, SG
Session: Welcome and Introduction
Resources:
Slides
Webcast
Mechanisms of gene fusion, fusion partners and consequences in oncogenesis. Description, structure and function of TRK and NTRK in ontogenesis
Presenter: A. Vivancos, ES
Session: SESSION 1 Keynote lecture Gene fusion in human cancer
Resources:
Slides
Webcast
Epidemiology and distribution of NTRK gene fusion in human tumours
Presenter: H. Loong, HK
Session: SESSION 2 Epidemiology and distribution of NTRK gene fusion in human tumours
Resources:
Slides
Webcast
Identification/testing methodologies and challenges
Presenter: C. Marchio, IT
Session: SESSION 3 – Identification/testing methodologies and challenges
Resources:
Slides
Webcast
Multi Kinases inhibitors with NTRK as a possible target
Presenter: M. Tahara, JP
Session: SESSION 4 – Clinical development of NTRK inhibitors – Part 1
Resources:
Slides
Webcast
Tolerance profile and recommendation for use
Presenter: J. Lim, SG
Session: SESSION 4 – Clinical development of NTRK inhibitors – Part 1
Resources:
Slides
Webcast
Present results with larotrectinib
Presenter: U. N. Lassen, DK
Session: SESSION 4 – Clinical development of NTRK inhibitors – Part 1
Resources:
Slides
Webcast
Detection of gene fusion within the ESMO Scale for Clinical Actionability of Molecular Target (ESCAT)
Presenter: J. Mateo, ES
Session: SESSION 5 – Detection of gene fusion within the ESMO Scale for Clinical Actionability of Molecular Target (ESCAT)
Resources:
Slides
Webcast
Acquired resistance to NTRK inhibitors and development of inhibitors targeting resistance mutations
Presenter: U. N. Lassen, DK
Session: SESSION 6 – Clinical development of NTRK inhibitors – Part 2
Resources:
Slides
Webcast
Workshop 1 for medical oncologists
Presenter: C. E. Chee, SG, D. S. W. Tan, SG
Session: Workshop sessions
Resources:
Slides
Webcast